Susan K. Finston

Mrs. Susan K. Finston, Esq., is Amrita Therapeutics’ Chief Executive Officer and Managing Director.


Susan brings to Amrita twenty-five years of varied government and private sector legal experience with particular expertise in bio-pharmaceutical policy, development, and related intellectual property (IP) management. She has an extensive background in management of bio-pharmaceutical and drug development issues at the policy level, including in the IP and regulatory challenges facing biotechnology companies, and particular expertise relating to India and diseases of the developing world.


In 2005 she launched Finston Consulting LLC as an independent consultancy to provide advice to biotechnology companies including start-up, strategic partnering, licensing, tech transfer, clinical drug development, and policy advocacy. Previous experience includes 6 years at the Pharmaceutical Research and Manufacturers of America (PhRMA), where she was Associate Vice President for Intellectual Property, Middle East/Africa and South Asian Affairs. While at PhRMA, she led the international industry campaign for the successful amendment of India’s patent law to introduce product protection, and worked with the Hashemite Kingdom of Jordan and the Kingdom of Saudi Arabia on WTO accession and related pharmaceutical IP, trade and investment issues.


From 1988 to 1999, she served in the U.S. Foreign Service, specializing in legal negotiations in areas of intellectual property, trade and development, and receiving two Meritorious Honor Awards for achievements in the areas of trade and development. She served in the judicial branch of the U.S. Government for two years as a Motions Clerk at the federal Court of Appeals for the Seventh Circuit. Susan’s educational background includes a joint J.D./M.P.P awarded by the University of Michigan. She is a member of the Illinois Bar and the U.S. Supreme Court Bar.

A full listing of her board memberships, professional activities, awards and recent publications is available online at